Nuveen LLC Makes New $17.94 Million Investment in Alignment Healthcare, Inc. $ALHC

Key Points

• Nuveen LLC acquired 963,688 shares of Alignment Healthcare, Inc. valued at approximately $17.9 million, representing 0.49% of the company's total shares.
• Multiple large investors, including Vanguard Group and T. Rowe Price, significantly increased their stakes in Alignment Healthcare during the last quarter, showcasing strong institutional interest.
• The stock received a mix of ratings from analysts, with the average rating categorized as "Moderate Buy" and a target price of $18.56.

Nuveen LLC acquired a new position in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 963,688 shares of the company's stock, valued at approximately $17,944,000. Nuveen LLC owned approximately 0.49% of Alignment Healthcare as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently bought and sold shares of the company. Teacher Retirement System of Texas raised its position in Alignment Healthcare by 109.1% in the first quarter. Teacher Retirement System of Texas now owns 47,447 shares of the company's stock worth $883,000 after acquiring an additional 24,755 shares in the last quarter. Northern Trust Corp raised its position in Alignment Healthcare by 8.6% in the fourth quarter. Northern Trust Corp now owns 908,964 shares of the company's stock worth $10,226,000 after acquiring an additional 72,063 shares in the last quarter. New York State Common Retirement Fund raised its position in Alignment Healthcare by 100.9% in the first quarter. New York State Common Retirement Fund now owns 165,642 shares of the company's stock worth $3,084,000 after acquiring an additional 83,187 shares in the last quarter. Victory Capital Management Inc. raised its position in Alignment Healthcare by 905.7% in the first quarter. Victory Capital Management Inc. now owns 114,397 shares of the company's stock worth $2,130,000 after acquiring an additional 103,022 shares in the last quarter. Finally, GAMMA Investing LLC raised its position in Alignment Healthcare by 3,216.9% in the first quarter. GAMMA Investing LLC now owns 23,815 shares of the company's stock worth $443,000 after acquiring an additional 23,097 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company's stock.

Alignment Healthcare Price Performance

Shares of ALHC stock traded up $0.04 during mid-day trading on Friday, reaching $15.84. The stock had a trading volume of 2,885,734 shares, compared to its average volume of 4,031,600. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29. The company has a market cap of $3.14 billion, a P/E ratio of -56.57 and a beta of 1.16. Alignment Healthcare, Inc. has a 12-month low of $8.65 and a 12-month high of $21.06. The business has a 50-day simple moving average of $13.77 and a 200 day simple moving average of $15.30.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The business's revenue for the quarter was up 49.0% compared to the same quarter last year. During the same quarter last year, the company earned ($0.13) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, sell-side analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Insider Buying and Selling at Alignment Healthcare

In related news, President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction on Monday, July 14th. The stock was sold at an average price of $13.44, for a total transaction of $403,200.00. Following the sale, the president owned 2,042,899 shares of the company's stock, valued at $27,456,562.56. This trade represents a 1.45% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Joseph S. Konowiecki sold 25,000 shares of the stock in a transaction on Thursday, July 31st. The shares were sold at an average price of $16.00, for a total value of $400,000.00. Following the sale, the director directly owned 1,152,049 shares in the company, valued at approximately $18,432,784. The trade was a 2.12% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 624,153 shares of company stock valued at $9,037,301. 7.00% of the stock is owned by company insiders.

Analyst Ratings Changes

Several research analysts have issued reports on ALHC shares. Stephens upgraded Alignment Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Wall Street Zen cut Alignment Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, August 10th. Barclays upgraded Alignment Healthcare from an "underweight" rating to an "equal weight" rating and raised their price target for the company from $9.00 to $13.00 in a research report on Thursday, July 31st. Zacks Research upgraded Alignment Healthcare to a "hold" rating in a research report on Friday, August 8th. Finally, UBS Group raised their price target on Alignment Healthcare from $16.00 to $17.00 and gave the company a "neutral" rating in a research report on Friday, May 2nd. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $18.56.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.